EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients

Elin Dahlén iD, Carola Bardage, Paulina Tuvendal, Rickard Ljung

International Journal of Methods in Psychiatric Research · 2024-03 · 33 (1)

DOI: 10.1002/mpr.1998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Methods in Psychiatric Research, online erschienen am 13.02.2024. Verfasst von Elin Dahlén und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Swedish Medical Products Agency, Uppsala, Sweden. Hauptthemen laut MEDLINE: Anti-Anxiety Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Anxiety and sleep disorders are common in the population and anxiolytics and sedatives are widely used. Our aim was to describe the drug utilization of new users of anxiolytics and sedatives in adults including type of drug, doses, prescribers' characteristics, and psychiatric comorbidity.

Methods

A register‐based cohort study of new users (18–64 years) of anxiolytics and sedatives in 2015–2019, free of any such drug 5 years prior to inclusion. The individuals were linked to national registers on dispensed drugs and recorded diagnoses.

Results

In total, 764,432 new users of anxiolytics and sedatives were identified, which corresponds to an incidence of 26/1000 inhabitants and year. The proportion of new users of benzodiazepines (including both anxiolytics and sedatives) decreased, whereas the proportion of sedative antihistamines and melatonin increased. The most common drug dispensed was hydroxizin (33%) followed by benzodiazepine related drugs (zopiclone and zolpidem; 20%), propiomazine (14%) and benzodiazepines (13%). The majority (68%) of the prescriptions were from primary care. Most new users were prescribed 1–30DDDs and 52% among women and 49% among men were dispensed their drug only once during the first year. Half of the new users had a previous comorbid psychiatric disorder.

Conclusions

The findings are well reflecting the recommendations in national guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Anxiety AgentsMaleAdultHumansFemaleHypnotics and SedativesSwedenCohort StudiesBenzodiazepinesComorbidityDrug Prescriptions

Stichwörter der Autor:innen

anxietybenzodiazepinesincidencenew userssedatives

Substanzen

Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepines

Autor:innen und Institutionen

  • The Swedish Medical Products Agency, Uppsala, Sweden.
  • Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Elin Dahlén

Zitieren

APA

Dahlén, E., Bardage, C., Tuvendal, P., & Ljung, R. (2024). New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients. International Journal of Methods in Psychiatric Research, 33(1). https://doi.org/10.1002/mpr.1998

Vancouver

Dahlén E, Bardage C, Tuvendal P, Ljung R. New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients. International Journal of Methods in Psychiatric Research. 2024;33(1). doi:10.1002/mpr.1998

BibTeX
@article{Dahln2024,
  author = {Dahlén, Elin and Bardage, Carola and Tuvendal, Paulina and Ljung, Rickard},
  title = {New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients},
  journal = {International Journal of Methods in Psychiatric Research},
  year = {2024},
  volume = {33},
  number = {1},
  doi = {10.1002/mpr.1998}
}
Kostenlos starten →